| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.05 | 0.8 |